Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy

The purpose of this study was to compare 6-year visual outcomes of antivascular endothelial growth factor (anti-VEGF) monotherapy and initial combination therapy of photodynamic therapy (PDT) and anti-VEGF therapy for polypoidal choroidal vasculopathy (PCV) in a Chinese population and to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingyuan, Yuan, Mingzhen, Xia, Song, Chen, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948291/
https://www.ncbi.nlm.nih.gov/pubmed/31949949
http://dx.doi.org/10.1155/2019/1609717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948291/
https://www.ncbi.nlm.nih.gov/pubmed/31949949
http://dx.doi.org/10.1155/2019/1609717

Ejemplares similares